Tu1777 PROSPECTIVE EVALUATION OF ANAL SPHINCTER BOTULINUM TOXIN INJECTION FOR CHILDREN WITH HIRSCHSPRUNG DISEASE AND FUNCTIONAL CONSTIPATION
Desiree F. Baaleman(Emma Kinderziekenhuis), Peter L. Lu(Nationwide Children's Hospital), Desale Yacob(Nationwide Children's Hospital), Richard J. Wood(University of Massachusetts Amherst), Marc A. Levitt(Center for Children), Alexandra Hallagan(Nationwide Children's Hospital), Marc A. Benninga(Amsterdam University Medical Centers), Danielle Orsagh-Yentis(Nationwide Children's Hospital), Neetu Bali(Nationwide Children's Hospital), Karla Vaz(Nationwide Children's Hospital), Devin R. Halleran(Oregon Health & Science University)
Cited by 1
Related Papers
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
|Gastroenterology|2020|2.1k
Childhood Functional Gastrointestinal Disorders: Neonate/Toddler
|Gastroenterology|2016|1.1k
Evaluation and Treatment of Functional Constipation in Infants and Children
|Journal of Pediatric Gastroenterology and Nutrition|2013|1.1k
Epidemiology of constipation in children and adults: A systematic review
|Best Practice & Research Clinical Gastroenterology|2011|946
Epidemiology of Childhood Constipation: A Systematic Review
|The American Journal of Gastroenterology|2006|680